Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19
Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases such as type 2 diabetes mellitus and obesity and the pre...
Uloženo v:
| Vydáno v: | World journal of gastroenterology : WJG Ročník 27; číslo 33; s. 5502 |
|---|---|
| Hlavní autoři: | , , , , , , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
07.09.2021
|
| ISSN: | 2219-2840, 2219-2840 |
| On-line přístup: | Zjistit podrobnosti o přístupu |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases such as type 2 diabetes mellitus and obesity and the presence of metabolic-associated fatty liver disease (MAFLD), a high number of cases of patients affected by both MAFLD and COVID-19 would be expected, especially in high-risk populations. Some studies have shown an increased risk of adverse clinical outcomes, viral shedding, and deep vein thrombosis, especially in patients with MAFLD- related liver fibrosis. The predisposition to poor outcomes and severe acute respiratory syndrome coronavirus 2 infection in patients with MAFLD could be secondary to mechanisms common to both, including preexisting systemic chronic inflammation, endothelial dysfunction, and involvement of the renin-angiotensin system. Because of the increased risk of adverse outcomes, MAFLD should be screened in all patients admitted for COVID-19. Available computed tomography scans could be of help, assessment of liver fibrosis is also recommended, favoring noninvasive methods to limit the exposure of healthcare workers. Liver involvement in this population ranges from abnormalities in liver chemistry to hepatic steatosis in postmortem biopsies. Finally, preventive measures should be strongly advocated in patients already known to have MAFLD, including the use of telemedicine and vaccination in addition to general measures.Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases such as type 2 diabetes mellitus and obesity and the presence of metabolic-associated fatty liver disease (MAFLD), a high number of cases of patients affected by both MAFLD and COVID-19 would be expected, especially in high-risk populations. Some studies have shown an increased risk of adverse clinical outcomes, viral shedding, and deep vein thrombosis, especially in patients with MAFLD- related liver fibrosis. The predisposition to poor outcomes and severe acute respiratory syndrome coronavirus 2 infection in patients with MAFLD could be secondary to mechanisms common to both, including preexisting systemic chronic inflammation, endothelial dysfunction, and involvement of the renin-angiotensin system. Because of the increased risk of adverse outcomes, MAFLD should be screened in all patients admitted for COVID-19. Available computed tomography scans could be of help, assessment of liver fibrosis is also recommended, favoring noninvasive methods to limit the exposure of healthcare workers. Liver involvement in this population ranges from abnormalities in liver chemistry to hepatic steatosis in postmortem biopsies. Finally, preventive measures should be strongly advocated in patients already known to have MAFLD, including the use of telemedicine and vaccination in addition to general measures. |
|---|---|
| AbstractList | Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases such as type 2 diabetes mellitus and obesity and the presence of metabolic-associated fatty liver disease (MAFLD), a high number of cases of patients affected by both MAFLD and COVID-19 would be expected, especially in high-risk populations. Some studies have shown an increased risk of adverse clinical outcomes, viral shedding, and deep vein thrombosis, especially in patients with MAFLD- related liver fibrosis. The predisposition to poor outcomes and severe acute respiratory syndrome coronavirus 2 infection in patients with MAFLD could be secondary to mechanisms common to both, including preexisting systemic chronic inflammation, endothelial dysfunction, and involvement of the renin-angiotensin system. Because of the increased risk of adverse outcomes, MAFLD should be screened in all patients admitted for COVID-19. Available computed tomography scans could be of help, assessment of liver fibrosis is also recommended, favoring noninvasive methods to limit the exposure of healthcare workers. Liver involvement in this population ranges from abnormalities in liver chemistry to hepatic steatosis in postmortem biopsies. Finally, preventive measures should be strongly advocated in patients already known to have MAFLD, including the use of telemedicine and vaccination in addition to general measures.Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing coronavirus disease (COVID-19). Because of the close relationship between metabolic diseases such as type 2 diabetes mellitus and obesity and the presence of metabolic-associated fatty liver disease (MAFLD), a high number of cases of patients affected by both MAFLD and COVID-19 would be expected, especially in high-risk populations. Some studies have shown an increased risk of adverse clinical outcomes, viral shedding, and deep vein thrombosis, especially in patients with MAFLD- related liver fibrosis. The predisposition to poor outcomes and severe acute respiratory syndrome coronavirus 2 infection in patients with MAFLD could be secondary to mechanisms common to both, including preexisting systemic chronic inflammation, endothelial dysfunction, and involvement of the renin-angiotensin system. Because of the increased risk of adverse outcomes, MAFLD should be screened in all patients admitted for COVID-19. Available computed tomography scans could be of help, assessment of liver fibrosis is also recommended, favoring noninvasive methods to limit the exposure of healthcare workers. Liver involvement in this population ranges from abnormalities in liver chemistry to hepatic steatosis in postmortem biopsies. Finally, preventive measures should be strongly advocated in patients already known to have MAFLD, including the use of telemedicine and vaccination in addition to general measures. |
| Author | Solís-Ortega, Alberto Adrián García-Juárez, Ignacio González-Regueiro, José A Ruiz-Margáin, Astrid Campos-Murguía, Alejandro Román-Calleja, Berenice M Flores-García, Nayelli C Hurtado-Díaz-de-León, Ivonne Macías-Rodríguez, Ricardo Ulises |
| Author_xml | – sequence: 1 givenname: Alejandro surname: Campos-Murguía fullname: Campos-Murguía, Alejandro – sequence: 2 givenname: Berenice M surname: Román-Calleja fullname: Román-Calleja, Berenice M – sequence: 3 givenname: José A surname: González-Regueiro fullname: González-Regueiro, José A – sequence: 4 givenname: Ivonne surname: Hurtado-Díaz-de-León fullname: Hurtado-Díaz-de-León, Ivonne – sequence: 5 givenname: Alberto Adrián surname: Solís-Ortega fullname: Solís-Ortega, Alberto Adrián – sequence: 6 givenname: Nayelli C surname: Flores-García fullname: Flores-García, Nayelli C – sequence: 7 givenname: Ignacio surname: García-Juárez fullname: García-Juárez, Ignacio – sequence: 8 givenname: Astrid surname: Ruiz-Margáin fullname: Ruiz-Margáin, Astrid – sequence: 9 givenname: Ricardo Ulises surname: Macías-Rodríguez fullname: Macías-Rodríguez, Ricardo Ulises |
| BookMark | eNpNjD1PwzAURS0EEm1hZ_TIQIL9nNjJiMJXpUpdgLVynBfqKnFCn9uKf08kGJjuudK9Z87OwxCQsRspUmWy4v60-0yPYFKvVJrnAs7YDECWCRSZOP_Hl2xOtBMClMphxk5V54N3tuMj7mlEF_0R6Y5bIiTqMcSJQ8N7dFsbPPXEh3Zq0dZD510y7QbnbcSGtzbGb95N_z1vPKEl5D7w0UY_aYiffNzyav2xfExkecUuWtsRXv_lgr0_P71Vr8lq_bKsHlaJU6BjUpcaSitKkZcFGKdbo9tMW6ed0VYVgLLOpLK6blFpdAYyiUIrWbRorFYNLNjtr3fcD18HpLjpPTnsOhtwONAGclPIHJTM4Adnw2OL |
| ContentType | Journal Article |
| Copyright | The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Copyright_xml | – notice: The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| DBID | 7X8 |
| DOI | 10.3748/wjg.v27.i33.5502 |
| DatabaseName | MEDLINE - Academic |
| DatabaseTitle | MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| EISSN | 2219-2840 |
| GroupedDBID | --- 123 29R 2WC 36B 53G 5VR 7X8 8WL AAKDD ACGFO AENEX ALMA_UNASSIGNED_HOLDINGS CCEZO CHBEP CIEJG CS3 CW9 DIK DU5 E3Z EBS EJD F5P FRP GX1 HYE OK1 P2P RNS RPM TR2 XSB |
| ID | FETCH-LOGICAL-c326t-b9629a09059827c6f76f46ac6c76a382e1b413a6bfe36ec7241e06318fe7a63d2 |
| IEDL.DBID | 7X8 |
| ISICitedReferencesCount | 0 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000701735900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2219-2840 |
| IngestDate | Thu Jul 10 18:59:56 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | true |
| Issue | 33 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c326t-b9629a09059827c6f76f46ac6c76a382e1b413a6bfe36ec7241e06318fe7a63d2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://pubmed.ncbi.nlm.nih.gov/PMC8433612 |
| PQID | 2578152314 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_2578152314 |
| PublicationCentury | 2000 |
| PublicationDate | 20210907 |
| PublicationDateYYYYMMDD | 2021-09-07 |
| PublicationDate_xml | – month: 09 year: 2021 text: 20210907 day: 07 |
| PublicationDecade | 2020 |
| PublicationTitle | World journal of gastroenterology : WJG |
| PublicationYear | 2021 |
| SSID | ssj0023352 |
| Score | 2.3482842 |
| SecondaryResourceType | review_article |
| Snippet | Metabolic diseases are highly prevalent worldwide and have been associated with adverse clinical outcomes, including mortality, in patients developing... |
| SourceID | proquest |
| SourceType | Aggregation Database |
| StartPage | 5502 |
| Title | Clinical perspectives, assessment, and mechanisms of metabolic-associated fatty liver disease in patients with COVID-19 |
| URI | https://www.proquest.com/docview/2578152314 |
| Volume | 27 |
| WOSCitedRecordID | wos000701735900004&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV09T8MwELWAMrDwIUB8y0iMuE3sxE4mhAoIlsIAqFvlOA4KapNCQiv-PXep2w4sSGyJlMHyPd9d7vneEXIRCBWFoeAsVTZigbacJRbl8eJESI_bTMukGTaher2o34-fXMGtctcq5z6xcdRpabBG3kFoQawRfnA1_mA4NQrZVTdCY5W0BKQyiGrVX7AIHPuJcLgcnEoGbtib0ZQouNKZvr-1J1y1cyHakKTzX664iS93W_9d2TbZdJklvZ5BYYes2GKXTJ3u55COl12V1SXVC0FOeC5SOrLYAZxXo4qWGbzVgI1hbph21rMpzXRdf9Mh3uOgjtaheUGdMGtFsaJLu4-vDzdggj3ycnf73L1nbtYCM5DA1SyJJY-1F3so6KeMzJTMAqmNNEpqEXHrJxDuwHCZFdIaBYHfQnbjR5lVWoqU75O1oizsAaEhSsr4SRwKGwWB8DTq1cBfnqcMKgXxQ3I-38cBYBkJCl3Y8qsaLHfy6A_fHJMNjhdMkN1RJ6SVwXm1p2TdTOq8-jxroPADcU69kw |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+perspectives%2C+assessment%2C+and+mechanisms+of+metabolic-associated+fatty+liver+disease+in+patients+with+COVID-19&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Campos-Murgu%C3%ADa%2C+Alejandro&rft.au=Rom%C3%A1n-Calleja%2C+Berenice+M&rft.au=Gonz%C3%A1lez-Regueiro%2C+Jos%C3%A9+A&rft.au=Hurtado-D%C3%ADaz-de-Le%C3%B3n%2C+Ivonne&rft.date=2021-09-07&rft.issn=2219-2840&rft.eissn=2219-2840&rft.volume=27&rft.issue=33&rft.spage=5502&rft_id=info:doi/10.3748%2Fwjg.v27.i33.5502&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2219-2840&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2219-2840&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2219-2840&client=summon |